Substantial Portion Of Investor Claims In Biotech Company Stock-Drop Suit Remain
PHILADELPHIA — A federal judge in Pennsylvania on Feb. 16 ruled that shareholders in a securities class action lawsuit against a biotechnology company and three of its senior executives have sufficiently...To view the full article, register now.
Already a subscriber? Click here to view full article